PsychiatricTimes Members: Login | Register

|     

 
CMPMedica Asset Publisher

Parity Laws: Powerful Weapon—or Pipe Dream?
Psychiatric Times,  May 6, 2013
Grief and Depression: The Sages Knew the Difference
Psychiatric Times,  April 29, 2013
US Physicians and Burnout: Optimistic Psychiatrists Take Heart?
Psychiatric Times,  April 26, 2013
Lighting a Candle in Newtown
Psychiatric Times,  April 17, 2013
The Obama Plan—Spending Mental Health Money in All the Wrong Places
Psychiatric Times,  April 12, 2013


 
PATIENT RESOURCES
Bases, stages and 'working your way up': young peoples talk about non-coital practices and 'normal' sexual trajectories
researchonline.lshtm.ac.uk -
Towards Justice for Victims: A New Role for Victim Impact Statements in Sexual Violence Cases
researcharchive.vuw.ac.nz -
Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?
researchonline.lshtm.ac.uk -
 
CLINICAL TRIALS
ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction
www.clinicaltrials.gov -
Effects of Yohimbine and Naltrexone on Sexual Function
www.clinicaltrials.gov -
Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
www.clinicaltrials.gov -

Physiological Sexual Dysfunction
 
LATEST FEATURES
February 14, 2011
Drug Companies Peddle Female Sexual Dysfunction
Ray Moynihan (who previously gave us the invaluable book "Selling Sickness: How Drug Companies are Turning us All Into Patients") has published a new... More »
September 10, 2010
Exercise and Camaraderie Fight Aftereffects of Cancer
Patients are beating cancer only to fall prey to sexual dysfunction, body pain, and chronic disease. The physical symptoms of their success increase... More »
August 28, 2010
Major Depressive Disorder Quiz
More »
June 30, 2010
Antidepressant-Induced Sexual Dysfunction: Five Management Strategies
Selective serotonin reuptake inhibitors and other second-generation antidepressants have become common therapeutic options for the management of... More »
April 29, 2010
Can Dialogue Cure? A Couple's Therapeutic Journey
Individuals with a past history of chronic psychiatric illness are often given poor prognoses that can limit their therapeutic horizons for further... More »
November 22, 2009
SSRIs and Sexual Dysfunction
SSRIs and related antidepressants are great drugs for the treatment of depression, anxiety, premenstrual disorders, and other conditions. However,... More »
Showing 1 - 6 of 36 results.
Page of 6
First Previous Last
 
JOURNAL SCAN
JAMA Network | JAMA | InsomniaInsomnia
jama.jamanetwork.com - 2/19/13
The etiology and pathophysiology of insomnia involve genetic, environmental, behavioral, and physiological factors culminating in hyperarousal.
PLOS Genetics: A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function
www.plosgenetics.org - 2/6/13
PLOS Genetics is an open-access
PLOS ONE: Body Conscious? Interoceptive Awareness, Measured by Heartbeat Perception, Is Negatively Correlated with Self-Objectification
www.plosone.org - 2/5/13
PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world.
PLOS Genetics: Magel2 Is Required for Leptin-Mediated Depolarization of POMC Neurons in the Hypothalamic Arcuate Nucleus in Mice
www.plosgenetics.org - 1/16/13
PLOS Genetics is an open-access
RB&E | Full text | Germline cells in ovarian surface epithelium of mammalians: a promising notion
www.rbej.com - 12/16/12
It is a long held doctrine in reproductive biology that women are born with a finite number of oocytes and there is no oogenesis during the postnatal period. However, recent evidence challenges this by showing the presence of germ line stem cells in the human ovarian surface epithelium (OSE), which can serve as a source of germ cells, and differentiate into oocyte like structures. Postnatal renewal of oocytes may have enormous therapeutic potential especially in women facing the risk of premature ovarian
 
MEDLINE
Andropause (androgen deficiency of the aging male): diagnosis and management.
pubmed.gov - 9/30/12
Androgen deficiency of the aging male is a pathological syndrome and should not be viewed simply as a stage in physiological aging. It is often overlooked despite evidence for a deleterious impact on many physiological processes and on quality of life. Its identification should be part of the routine practice of physicians in charge of this population, in particular general practitioners and specialists treating associated comorbidities (e.g. metabolic syndrome, diabetes, cardiovascular disorders) or sexual dysfunction. The consultant urologist has a key role to play in prostate surveillance before and during treatment. Treatment is often simple with few side-effects. However, long-term benefits and side effects need to be investigated in prospective studies.
Topical testosterone supplementation for the treatment of male hypogonadism.
pubmed.gov - 8/19/12
Age-related hormonal decline is gradual and less recognized in men than in women. Symptoms are oftentimes ignored and non-specific. Fatigue, lack of concentration, mood swings, decreased sexual desire, erectile dysfunction, infertility, hair loss, reduced muscle and bone mass, and weight gain are a few of the symptoms of male hypogonadism. This disorder is linked to reduction in quality of life, and poorer health outcomes as it may increase the risk for cardiovascular disease, diabetes mellitus, metabolic syndrome, Alzheimer's disease and premature death. Different modalities of testosterone replacement therapy have evolved over 70 years, and sales continue to grow. Each preparation is differentiated by route of delivery, ease of use, cost and pharmacokinetics. Topical/transdermal testosterone replacement therapy, including patches and gels, are the most modern formulations on the market. These are more expensive treatments, but yield more physiological concentrations of testosterone.
Hypoactive sexual desire disorder.
pubmed.gov - 8/1/12
Hypoactive sexual desire disorder (HSDD) is the most prevalent female sexual dysfunction, with estimates of prevalence approximating 10%. By definition it is a deficiency of sexual desire that causes distress. HSDD has no single cause, but physiological, psychological and socio-cultural factors underpinning female sexual desire may all be important in its development.|Medical therapeutic strategies to date have concentrated on modulation of hormone levels, particularly androgen administration, yet few products have been approved for the treatment of HSDD in developed countries. More recent medical targets have included agents with 5-hydroxytryptamine agonist activity. Psychological therapeutic approaches have been infrequently studied but concentrate on cognitive behavioural therapy.|HSDD is an evolving diagnosis, the existence of which has been questioned by some critics. Whilst HSDD remains the subject of ongoing research, its title and definition are under debate as a new edition
A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer.
pubmed.gov - 5/1/12
The goal of this study was to evaluate a mindfulness-based cognitive behavioral intervention for sexual dysfunction in gynecologic cancer survivors compared to a wait-list control group.|Thirty-one survivors of endometrial or cervical cancer (mean age 54.0, range 31-64) who self-reported significant and distressing sexual desire and/or sexual arousal concerns were assigned either to three, 90-minute mindfulness-based cognitive behavior therapy sessions or two months of wait-list control prior to entering the treatment arm. Validated measures of sexual response, sexual distress, and mood, as well as laboratory-evoked physiological and subjective sexual arousal were assessed at pre-, one month post-, and 6-months following treatment.|There were no significant effects of the wait-list condition on any measure. Treatment led to significant improvements in all domains of sexual response, and a trend towards significance for reducing sexual distress. Perception of genital arousal during an
The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature.
pubmed.gov - 5/1/12
In this paper we review evidence concerning the impact of hematopoietic SCT (HSCT) on sexuality. The aims are to determine: (1) the sexual changes experienced by patients following allogeneic or autologous HSCT, and its consequences; (2) changes in the sexual function over time and (3) the impact of physiological changes induced by intensive treatment with radiation and chemotherapy on sexual functioning. Four databases were searched for articles published between January 1995 and May 2011. A total of 14 studies were identified and analyzed. We found that (1) multiple aspects of sexuality were affected, and the impact and etiology of these sexual alterations were different between genders, and (2) recovery of sexual activity and pleasure occurred in the first 2 years after HSCT, although it appears that some survivors are more likely to experience sexual dysfunction even 5-10 years after HSCT as compared with controls; and (3) there was contradictory evidence concerning possible
 
PRACTICE GUIDELINES
National Guideline Clearinghouse | Guidelines by Topic: Sexual Dysfunction, Physiological
www.guidelines.gov -
NGC is the National Guideline Clearinghouse.
Canadian consensus on menopause and osteoporosis
www.sogc.org -
Confrence canadienne de consensus sur la mnopause et lostoporose 2000/2001 Tir part du JOGC septembre 2001, volume 23, numro 9 octobre 2001, volume 23, numro 10 novembre 2001, volume 23, numro 11 dcembre 2001, volume 23,
Microsoft Word
www.auanet.org -
I. Introduction The three major forms of male sexual dysfunction are ejaculatory dysfunction, erectile dysfunction ( ED), and decreased libido ( hypoactive sexual desire disorder). ... The present guidelines and recommendations are based on the following



 
COMMENTS
 
Common Physiological Sexual Dysfunction Medications
 
CAREER CENTER